Marina is an early-mid career scientist with expertise in infectious disease, identifying novel drug targets and bioinformatics. Deep knowledge in these three complementary domains of medical research have been developed by high level training at the Peter Doherty Institute where she completed a PhD exploring a cure for HIV and at Weill Cornell Medical College in New York where she assisted the HIV vaccine development mission. She is currently at CSIRO as a CERC postdoc where she has gained skills to analyse next generation sequencing data in efforts to understand how SARS-Corona Virus-2 causes severe disease.